Literature DB >> 17469046

Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls.

Jakob R Larsen1, Taro Tsunoda, E Murat Tuzcu, Paul Schoenhagen, Magne Brekke, Harald Arnesen, Kristian F Hanssen, Steven E Nissen, Knut Dahl-Jorgensen.   

Abstract

AIMS/HYPOTHESIS: The extent of coronary atherosclerosis is significantly more advanced in symptomatic type 1 diabetes patients than in symptomatic non-diabetic patients. Whether this difference exists between asymptomatic individuals with diabetes and controls is not documented. In vivo imaging techniques allow quantification of the difference at a preclinical stage.
METHODS: The degree of coronary atherosclerosis in early onset type 1 diabetes patients without symptoms of cardiovascular disease was compared with that of age- and sex-matched controls. Intracoronary ultrasound (IVUS) examinations were performed to determine the degree of atherosclerosis. The mean age of the patients was 43 years (35-58), they had a mean duration of disease of 30 (23-39) years and the diagnosis of type 1 diabetes was made at a mean age of 12.5 years. The controls were people with transplanted hearts; donors were sex- and age-matched and had a mean age of 43 (35-58) years.
RESULTS: The degree of subclinical coronary atherosclerosis was significantly more severe in type 1 diabetes patients than in controls. This was the case for all parameters measured. The mean plaque area was >or= 40% in 71% (54/76) of diabetic arteries as opposed to 33% (25/76) of arteries from controls (p<0.0001). The mean plaque thickness was 0.59+/-0.38 mm vs. 0.44+/-0.30 mm in controls (p<0.0001). The mean lumen area was 8.6+/-3.8 mm2 in type 1 diabetes and 12.1+/-4.3 mm2 in controls (p<0.0001). CONCLUSIONS/
INTERPRETATION: Asymptomatic individuals with type 1 diabetes have significantly more advanced subclinical coronary atherosclerosis than controls. Coronary atherosclerosis in type 1 diabetes develops at an early age.

Entities:  

Mesh:

Year:  2007        PMID: 17469046     DOI: 10.3132/dvdr.2007.009

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  9 in total

Review 1.  Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Authors:  Hillary A Keenan; Ernesto Maddaloni
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 2.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

3.  Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.

Authors:  Rozh H Al-Mashhadi; Martin M Bjørklund; Martin B Mortensen; Christina Christoffersen; Torben Larsen; Erling Falk; Jacob F Bentzon
Journal:  Diabetologia       Date:  2015-05-31       Impact factor: 10.122

4.  Glycaemic status influences the nature and severity of coronary artery disease.

Authors:  C Berry; S Noble; J C Grégoire; R Ibrahim; S Levesquie; M-A Lavoie; P L L'Allier; J-C Tardif
Journal:  Diabetologia       Date:  2010-01-14       Impact factor: 10.122

Review 5.  Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?

Authors:  Uyen T Truong; David M Maahs; Stephen R Daniels
Journal:  Diabetes Technol Ther       Date:  2012-06       Impact factor: 6.118

6.  Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: impact of exercise training.

Authors:  Aaron J Trask; Maria A Delbin; Paige S Katz; Angelina Zanesco; Pamela A Lucchesi
Journal:  Vascul Pharmacol       Date:  2012-08-02       Impact factor: 5.773

Review 7.  Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.

Authors:  Sarah D de Ferranti; Ian H de Boer; Vivian Fonseca; Caroline S Fox; Sherita Hill Golden; Carl J Lavie; Sheela N Magge; Nikolaus Marx; Darren K McGuire; Trevor J Orchard; Bernard Zinman; Robert H Eckel
Journal:  Diabetes Care       Date:  2014-08-11       Impact factor: 19.112

8.  Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes.

Authors:  Kari Anne Sveen; Kristine Bech Holte; Mona Svanteson; Kristian F Hanssen; Jan Nilsson; Eva Bengtsson; Tore Julsrud Berg
Journal:  Diabetes Care       Date:  2021-04-15       Impact factor: 19.112

9.  Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-05-06       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.